Dr. Quentin Vanhaelen has more than 10 years of experience in system Biology, and bioinformatics, biology of aging and 5 years experience in ML/AI for drug discovery. He graduated from University of Brussels (ULB), Belgium with a master’s degree in theoretical physics. He pursued a PhD in physics in Brussels from 2006 to 2010 while undertaking several projects within the field of system biology. He was a postdoctoral researcher at the Ottawa Hospital Research Institute (OHRI), Canada from 2011 to 2013. His research focused on the modeling of the dynamics of signaling pathways and gene regulatory networks involved in stem cell fate decision. He founded his consultancy company, Insilicoscreen, a company developing computational models for signaling pathway analysis. This company was acquired by Insilico Medicine in 2015. Quentin Vanhaelen has authored and co-authored numerous peer-reviewed publications on topics such as non-equilibrium thermodynamics of fluid-fluid interface, evolutionary theories of aging and computational analysis of signaling pathway dynamics. He has written several chapters and edited two books, “Computational methods for drug repurposing” and “Computational Methods for estimating the kinetic parameters of biological systems”, published in the Springer series Methods in Molecular Biology. His research interests focus on the non-programmed theories of aging, dynamic analysis of signaling pathways dynamics and applications of ML/AI techniques for target identification, drug repurposing and discovery.